Regardless, early systemic chemokine induction following TransCon TLR7/8 Agonist treatment correlated with an increase in peripheral NK and myeloid cells, suggesting mobilization of cells that may participate in tumor killing and tumor antigen presentation, respectively. The gene discussed is TLR7; the disease is neoplasm.